Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

68Ga-DOTA-hLAG-3 PET Imaging of LAG-3 Expression in Cancers

NCT05346276 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Xiamen University as lead sponsor.

NCT NCT05346276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05346276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
68Ga-DOTA-hLAG-3 PET Imaging of LAG-3 Expression in Cancers
Lead sponsor
The First Affiliated Hospital of Xiamen University
Phase
Observational
Overall status
Completed
Start date
October 10, 2022
Completion date
December 13, 2024
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hlag-3, pet/ct, tumor